0000000000310252

AUTHOR

Andrea Igoren Guaricci

showing 9 related works from this author

Rationale, design and methods of CTCA-PRORECAD (Computed Tomography Coronary Angiography Prognostic Registry for Coronary Artery Disease): a multicen…

2013

PURPOSE: This study was done to assess the prognostic value of computed tomography coronary angiography (CTCA) in a large multicentre population of patients with suspected coronary artery disease (CAD) and, in particular, its incremental value compared with traditional methods for risk stratification. MATERIALS AND METHODS: This is a retrospective observational study that began in January 2003 conducted on patients with suspected CAD assessed with CTCA on the basis of symptoms (chest pain, dyspnoea) and/or abnormal or equivocal stress test and/or a high cardiovascular risk profile. The participating centres will provide data obtained with CTCA performed with 16-slice or higher equipment. Ex…

Coronary angiographyMaleContrast MediaComputed tomographyCoronary DiseaseCoronary AngiographyCoronary artery diseaseComputed tomography coronary angiographyCoronary artery diseaseComputer-AssistedRisk FactorsRegistriesTomographyNeuroradiologyeducation.field_of_studymedicine.diagnostic_testcomputed tomography coronary angiography; coronary artery disease; prevalence of disease; prognosis; registry; risk stratificationRadiographic Image InterpretationInterventional radiologyGeneral MedicineMiddle AgedPrognosisX-Ray ComputedResearch DesignRisk stratificationCardiologyPrevalence of diseaseRadiographic Image Interpretation Computer-AssistedFemaleRadiologymedicine.medical_specialtyRegistryPrognosiEndpoint DeterminationPopulationRisk AssessmentComputed tomography coronary angiography; Coronary artery disease; Prevalence of disease; Prognosis; Risk stratification; Registry; Analysis of Variance; Contrast Media; Coronary Disease; Endpoint Determination; Female; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; Radiographic Image Interpretation Computer-Assisted; Retrospective Studies; Risk Assessment; Risk Factors; Coronary Angiography; Registries; Research Design; Tomography X-Ray ComputedInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingeducationRisk stratificationProportional Hazards ModelsRetrospective StudiesAnalysis of Variancebusiness.industrymedicine.diseasebusinessTomography X-Ray ComputedLa Radiologia medica
researchProduct

Carotid intima media thickness and coronary atherosclerosis linkage in symptomatic intermediate risk patients evaluated by coronary computed tomograp…

2014

Background: There is a growing evidence that carotid intima media thickness (CIMT) is associated with coronary artery disease (CAD) and it should be used as a predictor of atherosclerotic burden of coronary arteries. However, these studies have been performed by using invasive coronary angiography (ICA) and in high-risk patients for CAD. The purpose of this study was to evaluate the correlation between CIMT by ultrasound and coronary atherosclerosis in symptomatic intermediate risk patients by coronary computed tomography angiography (CCTA). Methods: We enrolled 204 consecutive symptomatic patients (mean age: 61 +/- 10; men: 118) and intermediate risk for CAD. All patients underwent CIMT ul…

Malemedicine.medical_specialtyCoronary atherosclerosiCoronary Artery DiseaseCoronary AngiographyCarotid Intima-Media ThicknessSeverity of Illness IndexCoronary artery diseasePredictive Value of TestsRisk FactorsInternal medicinemedicineCoronary computed tomography angiographyHumanscardiovascular diseasesCoronary atherosclerosisAgedCarotid intima media thicknebusiness.industryUltrasoundCoronary computed tomography angiographyMiddle Agedmedicine.diseaseCoronary arteriesmedicine.anatomical_structureIntima-media thicknessROC Curvecardiovascular systemCardiologyFemaleRadiologyCardiology and Cardiovascular MedicinebusinessIntermediate riskTomography X-Ray ComputedArteryInternational journal of cardiology
researchProduct

Appropriateness criteria for the use of cardiac computed tomography, SIC-SIRM part 2: Acute chest pain evaluation; Stent and coronary artery bypass g…

2022

In the past 20 years, cardiac computed tomography (CCT) has become a pivotal technique for the noninvasive diagnostic workup of coronary and cardiac diseases. Continuous technical and methodological improvements, combined with fast growing scientific evidence, have progressively expanded the clinical role of CCT. Randomized clinical trials documented the value of CCT in increasing the cost-effectiveness of the management of patients with acute chest pain presenting in the emergency department, also during the pandemic. Beyond the evaluation of stents and surgical graft patency, the anatomical and functional coronary imaging have the potential to guide treatment decision-making and planning …

Chest PainHeart DiseasesInterventionalCardiologyGeneral Medicineheart diseaseRadiology Interventionalvalve diseaseX-Ray Computedcoronary computed tomography scancoronary artery bypass graftNeoplasmsHumansStentsstentCoronary Artery BypassCardiology and Cardiovascular MedicineTomography X-Ray ComputedCardiomyopathiesRadiologychest pain; coronary artery bypass graft; coronary computed tomography scan; heart disease; stent; valve disease; Chest Pain; Coronary Artery Bypass; Humans; Radiology Interventional; Stents; Tomography X-Ray Computed; Cardiology; Cardiomyopathies; Heart Diseases; NeoplasmsTomographyvalve disease.
researchProduct

SIRM–SIC appropriateness criteria for the use of Cardiac Computed Tomography. Part 1: Congenital heart diseases, primary prevention, risk assessment …

2021

AbstractIn the past 20 years, Cardiac Computed Tomography (CCT) has become a pivotal technique for the noninvasive diagnostic work-up of coronary and cardiac diseases. Continuous technical and methodological improvements, combined with fast growing scientific evidence, have progressively expanded the clinical role of CCT. Recent large multicenter randomized clinical trials documented the high prognostic value of CCT and its capability to increase the cost-effectiveness of the management of patients with suspected CAD. In the meantime, CCT, initially perceived as a simple non-invasive technique for studying coronary anatomy, has transformed into a multiparametric “one-stop-shop” approach abl…

genetic structuresCardiac computed tomographyComputed Tomography AngiographyCoronary DiseaseCAD030204 cardiovascular system & hematologyChest painChest pain Congenital heart disease Coronary CT angiography Epicardial adipose tissue Plaque Stenosislaw.inventionChest painCongenital0302 clinical medicineRandomized controlled triallaw030212 general & internal medicineHeart DefectsPlaqueNeuroradiologyStenosismedicine.diagnostic_testCalcinosisHeartInterventional radiologyGeneral MedicineFractional Flow ReserveFractional Flow Reserve MyocardialPrimary PreventionPosition PaperChest pain; Congenital heart disease; Coronary CT angiography; Epicardial adipose tissue; Plaque; Stenosis; Calcinosis; Coronary Disease; Coronary Stenosis; Fractional Flow Reserve Myocardial; Heart; Heart Defects Congenital; Humans; Primary Prevention; Cardiac Imaging Techniques; Computed Tomography Angiography; Preoperative Caremedicine.symptomRisk assessmentHeart Defects Congenitalmedicine.medical_specialty03 medical and health sciencesEpicardial adipose tissuePreoperative CaremedicineMyocardialHumansRadiology Nuclear Medicine and imagingCoronary CT angiographyIntensive care medicineCongenital heart diseasebusiness.industryCoronary Stenosismedicine.diseaseCardiac Imaging TechniquesStenosisbusinessLa radiologia medica
researchProduct

Incremental value and safety of oral ivabradine for heart rate reduction in computed tomography coronary angiography

2012

Background: Heart rate (HR) reduction is essential to achieve optimal image quality and diagnostic accuracy with computed tomography coronary angiography (CTCA). Administration of ivabradine could be an attractive alternative to beta-blockade to reduce HR. Methods: One-hundred-twenty-three patients referred for CTCA were prospectively enrolled. Patients were divided in two groups depending on the absence or presence of chronic beta-blockade treatment. Within the two groups patients were randomized to either no additional premedication or oral ivabradine for 5 days prior to CTCA. In presence of chronic beta-blockade therapy it was shifted to atenolol 50 mg twice a day for 5 days prior to CTC…

MaleCoronary angiographymedicine.medical_specialtyAdministration OralComputed tomographyCoronary Artery DiseaseCoronary AngiographyComputed tomography coronary angiographyHeart RateInternal medicineHeart rateBradycardiamedicineHumansIvabradineIn patientProspective StudiesHeart rate reductionAgedmedicine.diagnostic_testbusiness.industryBenzazepinesMiddle AgedAtenololCoronary heart diseaseBlood pressureAnesthesiaCardiologyFemalePremedicationTomography X-Ray ComputedCardiology and Cardiovascular MedicinebusinessIvabradinemedicine.drugInternational Journal of Cardiology
researchProduct

Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry

2022

Aims: Sacubitril/valsartan has changed the treatment of heart failure with reduced ejection fraction (HFrEF), due to the positive effects on morbidity and mortality, partly mediated by left ventricular (LV) reverse remodelling (LVRR). The aim of this multicenter study was to identify echocardiographic predictors of LVRR after sacubitril/valsartan administration. Methods and results: Patients with HFrEF requiring therapy with sacubitril/valsartan from 13 Italian centres were included. Echocardiographic parameters including LV global longitudinal strain (GLS) and global peak atrial longitudinal strain by speckle tracking echocardiography were measured to find the predictors of LVRR [= LV end-…

EchocardiographyUltrasoundRemodellingHeart failureSacubitril/valsartanBiomarkers Cardiovascular disease Echocardiography Heart failure Imaging Remodelling Sacubitril/valsartan Speckle tracking UltrasoundCardiology and Cardiovascular MedicineCardiovascular diseaseBiomarkers; Cardiovascular disease; Echocardiography; Heart failure; Imaging; Remodelling; Sacubitril/valsartan; Speckle tracking; Ultrasound.BiomarkersImagingSpeckle tracking
researchProduct

Heart rate control with oral ivabradine in computed tomography coronary angiography: a randomized comparison of 7.5 mg vs 5 mg regimen.

2013

Background: Heart rate (HR) reduction is essential to achieve optimal image quality and diagnostic accuracy with computed tomography coronary angiography (CTCA). Administration of oral ivabradine seems to be more effective than beta-blockade in reducing HR in patients referred for CTCA. Methods: Two-hundred-fifty-nine consecutive patients referred for CTCA were prospectively enrolled. Patients not receiving beta-blocker at baseline (group 1) and those with beta-blocker therapy (group 2) were enrolled in the study. Each group was randomized into 3 parallel arms with 1:1:1 allocation. Patients who did not receive beta-blocker at baseline: underwent CTCA without beta blocker (n=49), and receiv…

Coronary angiographyMalemedicine.medical_specialtymedicine.drug_classAdministration OralComputed tomographyCoronary Artery DiseaseCoronary AngiographyComputed tomography coronary angiographyCohort StudiesHeart RateInternal medicineHeart ratemedicineHumansIvabradineProspective StudiesHeart rate reductionBeta blockerDose ModificationAgedRetrospective Studiesmedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryBenzazepinesMiddle AgedCoronary heart diseaseRegimenBlood pressureAnesthesiaCardiologyFemaleCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedIvabradinemedicine.drug
researchProduct

Coronary artery calcium score on low-dose computed tomography for lung cancer screening

2013

Aim: To evaluate the feasibility of coronary artery calcium score (CACS) on low-dose non-gated chest CT (ngCCT). Methods: Sixty consecutive individuals (30 males; 73 ± 7 years) scheduled for risk stratification by means of unenhanced ECG-triggered cardiac computed tomography (gCCT) underwent additional unenhanced ngCCT. All CT scans were performed on a 64-slice CT scanner (Somatom Sensation 64 Cardiac, Siemens, Germany). CACS was calculated using conventional methods/scores (Volume, Mass, Agatston) as previously described in literature. The CACS value obtained were compared. The Mayo Clinic classification was used to stratify cardiovascular risk based on Agatston CACS. Differences and corre…

High-resolution computed tomographymedicine.medical_specialtyCoronary artery calcium scoreunenhanced chest computed tomographymedicine.diagnostic_testbusiness.industryCoronary artery calcium scorecardiovascular risk stratificationLow dosenutritional and metabolic diseasesComputed tomographyLower riskEffective dose (radiation)SurgeryLung cancer screeningcardiovascular systemmedicineProspective Studycardiovascular diseasesSettore MED/36 - Diagnostica Per Immagini E RadioterapiaAgatston scoreNuclear medicinebusinessHigh-resolution computed tomographyLung cancer screeningWorld Journal of Radiology
researchProduct

Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-AR…

2021

Abstract Aims This sub-study deriving from a multicentre Italian register [Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry (DISCOVER)-ARNI] investigated whether sacubitril/valsartan in addition to optimal medical therapy (OMT) could reduce the rate of implantable cardioverter-defibrillator (ICD) indications for primary prevention in heart failure with reduced ejection fraction (HFrEF) according to European guidelines indications, and its potential predictors. Methods and results In this observational study, consecutive patients with HFrEF eligible for sacubitril/valsartan from 13 Italian centres were included. Lack o…

Left ventricular strainHeart failure; Implantable cardioverter-defibrillator; Left ventricular strain; Remodelling; Sacubitril/valsartanRemodellingHeart failureSacubitril/valsartanHeart failure Implantable cardioverter-defibrillator Left ventricular strain Remodelling Sacubitril/valsartanImplantable cardioverter-defibrillator
researchProduct